Susan Huyck

机构：Merck & Co., Inc., Rahway, NJ, USA (United States) · ORCID：0000-0001-8587-7431

发表论文 75 篇 · 总被引 5237 次 · h-index 24

代表论文

Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes (2020 · New England Journal of Medicine · 被引 1517)
Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes (2020 · JAMA Cardiology · 被引 1235)
Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV) (2018 · American Heart Journal · 被引 205)
Long‐term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104‐week VERTIS MET trial (2019 · Diabetes Obesity and Metabolism · 被引 66)
Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia (2019 · Diabetes Obesity and Metabolism · 被引 53)
Results of VERTIS SU extension study: safety and efficacy of ertugliflozin treatment over 104 weeks compared to glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin (2019 · Current Medical Research and Opinion · 被引 50)